BIOCON
Biocon is a global biopharmaceutical company focused on innovation-led development and manufacturing of affordable biosimilars, generic formulations, and complex APIs. It operates across generics, biosimilars, novel biologics, branded formulations, and research services, with a multinational presence in the biopharmaceutical landscape. The company emphasizes access to medicines and a broad portfolio spanning diabetes, oncology, and immunology. Headquartered in India, Biocon positions itself as a leading player in the global biopharmaceutical industry.